col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


23 Results       Page 1

 [1] 
Wiley: Immunology and Cell Biology
  original article Date Title Authors   All Authors
1 [GO] 2026―Mar―09 The role of peripheral serotonin in SARS - CoV -2 infectivity, COVID -19 treatment and long COVID Daniel W Thorpe, Lauren A Jones, Alyce M Martin, Rosemary A Coleman, Caitlin Allman, Rochelle A Peterson, Damien J Keating
2 [GO] 2025―Mar―11 Exploratory analyses of leukocyte responses in hospitalized patients treated with ozanimod following a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection Olivier Courtemanche, Pascale Blais-Lecours, Sylvie Lesage, Geneviève Chabot-Roy, Lise Coderre, Marie-Renée Blanchet, et al. (+3)
3 [GO] 2023―Sep―19 Broad spectrum SARS-CoV-2-specific immunity in hospitalized First Nations peoples recovering from COVID-19 Wuji Zhang, E Bridie Clemens, Lukasz Kedzierski, Brendon Y Chua, Mark Mayo, Claire Lonzi, et al. (+19)
4 [GO] 2023―Aug―21 Serological assays to measure dimeric IgA antibodies in SARS-CoV-2 infections Zihui Wei, Fiona Angrisano, Emily M Eriksson, Ramin Mazhari, Huy Van, Shuning Zheng, et al. (+9)
5 [GO] 2023―Jul―04 SARS-CoV-2 clearance after breakthrough infection correlates with fit and happy cells Marc Veldhoen, Antonio Bertoletti
6 [GO] 2023―May―22 SARS-CoV-2 clearance after breakthrough infection correlates with fit and happy T cells Marc Veldhoen, Antonio Bertoletti
7 [GO] 2023―Mar―28 ChAdOx1 nCoV -19 vaccination generates spike-specific CD8 + T cells in aged mice William S Foster, Joseph Newman, Nazia Thakur, Alexandra J Spencer, Sophie Davies, Danielle Woods, et al. (+7)
8 [GO] 2023―Feb―24 T follicular helper cell responses to SARS-CoV -2 vaccination among healthy and immunocompromised adults Mollie Ailie Acheson Boyd, Alexandra Carey Hoppe, Anthony D Kelleher, C Mee Ling Munier
9 [GO] 2023―Jan―26 Circulating effector γδ T cell populations are associated with acute coronavirus disease 19 in unvaccinated individuals Anouk von Borstel, Thi HO Nguyen, Louise C Rowntree, Thomas M Ashhurst, Lilith F Allen, Lauren J Howson, et al. (+9)
10 [GO] 2022―Dec―19 New-onset type 1 diabetes and SARS-CoV -2 infection Roy Anindya, Guy A Rutter, Gargi Meur
11 [GO] 2022―Mar―30 SARS-CoV-2 vaccine-induced B cells aspire to long-lived connections Liam Kealy, Kim L Good-Jacobson
12 [GO] 2022―Feb―21 The vaccinia-based Sementis Copenhagen Vector COVID-19 vaccine induces broad and durable cellular and humoral immune responses Preethi Eldi, Tamara H Cooper, Natalie A Prow, Liang Liu, Gary K Heinemann, Voueleng J Zhang, et al. (+6)
13 [GO] 2021―Dec―05 The benefit of boosters: diversity and inclusion in the COVID-19 memory response Gemma E Hartley, Menno C Zelm, Marcus J Robinson
14 [GO] 2021―Oct―21 Vaccine-induced immune thrombosis and thrombocytopenia syndrome following adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccination: a novel hypothesis regarding mechanisms and implications for future vaccine development Paul Monagle, Ashley P Ng, Matthew Linden, Vera Ignjatovic, Alison Farley, Samir Taoudi, et al. (+2)
15 [GO] 2021―Sep―28 Comprehensive immune cell profiling depicts an early immune response associated with severe COVID-19 disease in cancer patients Prashant R Tembhare, Harshini N Sriram, Gaurav Chatterjee, Twinkle Khanka, Anant Gokarn, Sumeet Mirgh, et al. (+21)
16 [GO] 2021―Aug―06 Walking down the memory lane with SARS-CoV-2 B cells Natalia T Freund, Motti Gerlic, Ben A Croker
17 [GO] 2021―Jul―26 Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19 Michael S Abers, Lindsey B Rosen, Ottavia M Delmonte, Elana Shaw, Paul Bastard, Luisa Imberti, et al. (+9)
18 [GO] 2021―Jun―04 SARS-CoV-2-specific CD8 + T-cell responses and TCR signatures in the context of a prominent HLA-A*24:02 allomorph Louise C Rowntree, Jan Petersen, Jennifer A Juno, Priyanka Chaurasia, Kathleen Wragg, Marios Koutsakos, et al. (+6)
19 [GO] 2021―May―30 Monocytes and macrophages in severe COVID-19 - friend, foe or both? Regine J Dress, Florent Ginhoux
20 [GO] 2020―Oct―28 COVID-19, varying genetic resistance to viral disease, and immune tolerance checkpoints Christopher C Goodnow
21 [GO] 2020―Aug―31 Antibody detection assays for COVID-19 diagnosis: an early overview Sarfaraz Ahmad Ejazi, Sneha Ghosh, Nahid Ali
22 [GO] 2020―Aug―31 Angiotensin-Converting Enzyme as a new immunologic target for the new SARS-CoV-2 Shahin Hallaj, Anahita Ghorbani, Seyed Ali Mousavi-Aghdas, Mohammad Mirza-Aghazadeh-Attari, Andrey Sevbitov, Vida Hashemi, et al. (+2)
23 [GO] 2020―Apr―22 COVID-19: searching for clues among other respiratory viruses Catriona Nguyen-Robertson, Ashraful Haque, Justine Mintern, Anne C La Flamme
 [1] 

23 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec